Christine Ann Fox, Chief Financial Officer at Mereo BioPharma Group plc (MREO), sold 71,868 shares at $3.39 ($248K) on 2024-06-26, disclosed to the SEC on 2024-06-27.
Open-market sale of $248k MREO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.69 | 12,990 | $48K | 19.4% |
| 2 | $3.39 | 29,439 | $100K | 40.3% |
| 3 | $3.39 | 29,439 | $100K | 40.3% |
| Total | $3.44 avg | 71,868 | $248K | 100% |